⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cysteamine SCHEMBL5666809 | 0.88 | CYP3A4 (0.36) | — | |
| SCHEMBL5971223 | 0.78 | — | — | |
| SCHEMBL19042804 | 0.78 | — | — | |
| SCHEMBL5470071 | 0.75 | RNPEP (0.38) | — | |
| SCHEMBL5469952 | 0.75 | RNPEP (0.39) | — | |
| SCHEMBL7098138 | 0.74 | — | — | |
| SCHEMBL154271 | 0.73 | — | — | |
| SCHEMBL4871212 | 0.73 | — | — | |
| SCHEMBL22129946 | 0.73 | — | — | |
| SCHEMBL758856 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116924954-A | Complexing agent, preparation method and impurity removal method of trichlorosilane | 新特能源股份有限公司 | 2023-10-24 | — | — | CN | claimed |
| US-4545985-A | ANTICARCINOGENIC AGENTS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES (US) | 1985-10-08 | — | — | US | claimed |
| US-20250241872-A1 | AFFINITY MEDICANT CONJUGATE | Illudent, Inc. (US) | 2025-07-31 | — | — | US | disclosed |
| CN-119529092-A | Anti-ACVR 2A antibodies and uses thereof | 来凯医药科技(上海)有限公司 | 2025-02-28 | — | — | CN | disclosed |
| CN-119039440-A | Depletion of activated Hepatic Stellate Cells (HSCs) and uses thereof | 来凯医药科技(上海)有限公司 | 2024-11-29 | — | — | CN | disclosed |
| CN-111201031-B | Anti-CD 47 x anti-mesothelin antibodies and methods of use thereof | 诺夫免疫股份有限公司 | 2024-11-01 | — | — | CN | disclosed |
| CN-118369580-A | Efficient labelling of antibodies with oligonucleotide labelling | 阿克托姆有限责任公司 | 2024-07-19 | — | — | CN | disclosed |
| CN-118176018-A | Anti-ACVR 2A antibodies and uses thereof | 来凯医药科技(上海)有限公司 | 2024-06-11 | — | — | CN | disclosed |
| CN-117980328-A | Depletion of activated Hepatic Stellate Cells (HSCs) and uses thereof | 来凯医药科技(上海)有限公司 | 2024-05-03 | — | — | CN | disclosed |
| CN-117412992-A | Bispecific antibodies targeting CD47 and PD-L1 and methods of use thereof | 诺夫免疫股份有限公司 | 2024-01-16 | — | — | CN | disclosed |
| CN-117180198-A | Annular mRNA drug delivery system | 奥明(杭州)生物医药有限公司 | 2023-12-08 | — | — | CN | disclosed |
| EP-0233287-A1 | 1,4-THIAZINE DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND CARDIOTONICS CONTAINING THE SAME | ZENYAKU KOGYO KABUSHIKIKAISHA (JP) | 1987-08-26 | — | — | EP | disclosed |
| EP-0214053-A1 | Modified protein supports for covalent or reversible immobilizing antibodies or immunologically active substances, and their uses in measuring and purifying antigens or the like | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 1987-03-11 | — | — | EP | disclosed |
| EP-0028778-B1 | ANTIBACTERIAL COMPOSITIONS COMPRISING A BETA-LACTAM-TYPE COMPOUND AND A 3-SUBSTITUTED PROPENOATE | MERCK & CO. INC. (US) | 1985-01-16 | — | — | EP | disclosed |
| US-4394520-A | SKIN DISORDERS | SOCIETE ANONYME DITE: L'OREAL (FR) | 1983-07-19 | — | — | US | disclosed |
| US-4298686-A | HIGH SENSITIVITY, AUTOMATIC | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 1981-11-03 | — | — | US | disclosed |
| US-4204064-A | FOR TREATMENT OF SKIN OR SCALP | L'OREAL (FR) | 1980-05-20 | — | — | US | disclosed |
| EP-0007879-A1 | Delta 5,3-cetosteroid isomerase and its use in immuno-enzyme quantifications | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 1980-02-06 | — | — | EP | disclosed |
| US-3976781-A | SULFUR CONTAINING AMINES | L'OREAL (FR) | 1976-08-24 | — | — | US | disclosed |
| US-3966801-A | ANTIINFLAMMATORY AGENTS | WILLIAM H. RORER, INC. (US) | 1976-06-29 | — | — | US | disclosed |